8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2022 / Systematic review and meta-analysis
A systematic review and meta-analysis evaluated the effects of high-fructose corn syrup (HFCS) versus sucrose across 4 articles with 767 participants, where sweetener usage averaged 19% of daily caloric intake. Compared to sucrose, HFCS intake did not significantly change weight (WMD: -0.29 kg, 95% CI: -1.34 to 0.77, I2 = 0%), waist circumference, BMI, fat mass, TC, HDL, LDL, TG, SBP, or DBP. However, data from three studies showed a significant increase in CRP levels in the HFCS group compared to sucrose (WMD: 0.27 mg/l, 95% CI: 0.02 to 0.52, I2 = 23%).
Li X, Luan Y, Li Y, et al. Front Nutr, 2022. PMID 36238453
2021 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis of 9 randomized controlled trials with 448 older adults evaluated the effects of HMB supplementation on body composition. HMB supplementation significantly increased fat-free mass compared to controls (effect size: 0.37; 95% CI 0.16, 0.58; P = 0.001) but showed no effect on fat mass (effect size: -0.04; 95% CI -0.26, 0.18; P = 0.716). Subgroup analysis indicated that HMB alone improved fat-free mass (effect size: 0.59; 95% CI 0.32, 0.87; P < 0.001), while HMB combined with exercise showed no additional change (effect size: 0.06; 95% CI -0.26, 0.38; P = 0.705).
Lin Z, Zhao Y, Chen Q Eur Geriatr Med, 2021. PMID 33034021
2021 / Umbrella review of systematic reviews and meta-analyses
An umbrella review examined 41 meta-analyses with 45 unique health outcomes in humans to evaluate the evidence on milk intake. Dose-response analyses indicated that a 200 ml per day increment in milk intake was linked to a lower risk of cardiovascular disease, stroke, hypertension, colorectal cancer, metabolic syndrome, obesity, and osteoporosis, with beneficial associations also observed for type 2 diabetes mellitus and Alzheimer's disease. Conversely, milk intake was associated with a higher risk of prostate cancer, Parkinson's disease, acne, and iron-deficiency anemia in infancy, with caution noted for potential allergy or lactose intolerance.
Shows an association, not proof of cause and effect.
Zhang X, Chen X, Xu Y, et al. Nutr Metab (Lond), 2021. PMID 33413488
2021 / Systematic review and meta-analysis of randomized clinical trials
A systematic review and meta-analysis evaluated 23 randomized trials (1,357 participants) testing low (<130 g/day or <26% energy) and very low (<10% energy) carbohydrate diets (LCDs and VLCDs) for at least 12 weeks in adults with type 2 diabetes. At six months, LCDs achieved higher rates of diabetes remission defined as HbA1c <6.5% compared to control diets (57% vs 31%; risk difference 0.32, 95% CI 0.17 to 0.47), though effect sizes were smaller and non-significant when remission was defined as HbA1c <6.5% without medication. Clinically important improvements in weight loss, triglycerides, and insulin sensitivity at six months diminished by 12 months, and data on 12-month remission were sparse. At 12 months, participants experienced clinically important but not statistically significant worsening of quality of life and LDL cholesterol.
Goldenberg JZ, Day A, Brinkworth GD, et al. BMJ, 2021. PMID 33441384
2021 / Systematic review and meta-analysis of experimental studies
A systematic review and meta-analysis of 19 experimental studies evaluated the effect of resveratrol supplementation for the treatment of obesity. Resveratrol had no significant effect on weight loss (SMD: 0.03; 95% CI: -0.44, 0.49; p = 0.01; I2 = 82%) or BMI (SMD: 0.01; 95% CI: -0.39, 0.41; p = 0.01; I2 = 72%). A small effect was observed on waist circumference (SMD: -1.04; 95% CI: -1.86, -0.27; p = 0.01; I2 = 87%). The authors concluded that resveratrol supplementation does not exert an anti-obesity effect.
Delpino FM, Figueiredo LM, Caputo EL, et al. Clin Nutr ESPEN, 2021. PMID 33487308
2021 / Systematic review
A systematic review synthesized data on 13 nutrition-related components and COVID-19 across 22 published articles, 38 preprint articles, and 79 trials identified up to August 2020. The authors found limited evidence that high-dose micronutrient supplements prevent severe disease or hasten recovery, with clinical trial results awaited. However, strong evidence indicates that the prevention of obesity and type 2 diabetes will reduce the risk of serious COVID-19 outcomes.
James PT, Ali Z, Armitage AE, et al. J Nutr, 2021. PMID 33982105
2021 / Systematic review and meta-analysis
A systematic review and meta-analysis of 384 studies, mostly cross-sectional, examined lifestyle-related risk factors for tinnitus. Current smoking (26 studies), ever smoking (16 studies), and obesity (seven studies) were associated with a significantly increased risk of tinnitus. In contrast, no effect was found for alcohol consumption (11 studies), and data were insufficient to draw conclusions regarding caffeine intake or coffee drinking (three studies).
Shows an association, not proof of cause and effect.
Biswas R, Lugo A, Genitsaridi E, et al. Prog Brain Res, 2021. PMID 34243884
2021 / Umbrella review of meta-analyses of randomized controlled trials
An umbrella review analyzed meta-analyses of randomized controlled trials examining resveratrol supplementation compared to control groups in patients with type 2 diabetes, metabolic syndrome, and NAFLD. While resveratrol showed beneficial effects on some markers (such as blood pressure, lipids, glycemic control, and waist circumference), the magnitude of effect was generally trivial, evidence certainty was very low to low, or trials were too few. Resveratrol showed a clinically important short-term (<12 weeks) reduction in HbA1c (mean difference: -1.05%, 95% CI: -2.09% to -0.02%; n = 6; moderate certainty), though evidence overall does not support supplementation for cardiometabolic management.
Zeraattalab-Motlagh S, Jayedi A, Shab-Bidar S Am J Clin Nutr, 2021. PMID 34320173
2021 / Systematic review and meta-analysis of randomized clinical trials
A systematic review and meta-analysis of randomized clinical trials evaluated the effects of omega-3 supplementation compared to placebo on lean body mass in humans across multiple databases. In total, 11 studies were included. While two individual studies found significant effects on lean body mass, none of the results were significant in the meta-analysis.
Delpino FM, Figueiredo LM Clin Nutr ESPEN, 2021. PMID 34330453
2021 / Systematic review and meta-analysis
A systematic review and meta-analysis of 42 studies with 423,117 patients assessed clinical risk factors associated with COVID-19 mortality. The pooled prevalence of mortality among hospitalized patients was 17.62% (95% CI 14.26-21.57%). Increased mortality risk was linked to older age (pOR 2.61, pHR 1.31), male sex (pOR 1.45, pHR 1.24), and current smoking status (pOR 1.42). Obesity, acute kidney injury, chronic obstructive pulmonary disease, cardiovascular disease, diabetes, hypertension, cancer, and increased D-dimer were also reported as clinical risk factors for fatal outcomes.
Shows an association, not proof of cause and effect.
Dessie ZG, Zewotir T BMC Infect Dis, 2021. PMID 34418980
2021 / Systematic review
Following PRISMA guidelines, researchers conducted a systematic review using databases including PubMed, Web of Science, Scopus, and Embase. Results showed that vegan diets are associated with improved gut microbiota symbiosis, increased insulin sensitivity, activation of peroxisome proliferator-activated receptors, and over-expression of mitochondrial uncoupling proteins. Key features reported were reduced calorie density and reduced cholesterol intake, suggesting plant-based and vegan diets might play a significant role in weight reduction strategies.
Shows an association, not proof of cause and effect.
Ivanova S, Delattre C, Karcheva-Bahchevanska D, et al. Foods, 2021. PMID 34945602
2021 / Systematic review of systematic reviews
A qualitative systematic review of systematic reviews and meta-analyses related to plantar fasciitis published up to February 2021 was conducted across major databases. Out of 1052 identified articles, 96 met inclusion criteria across the topics of epidemiology, diagnosis, and treatment. Although most reviews had high heterogeneity and a small number of studies, there was general consensus that BMI is a risk factor for plantar fasciitis and extracorporeal shockwave therapy is effective. The authors noted that evidence on topics such as epidemiology, exercise therapy, and cost-effectiveness remains lacking.
Shows an association, not proof of cause and effect.
Rhim HC, Kwon J, Park J, et al. Life (Basel), 2021. PMID 34947818
2020 / Meta-analysis of intervention studies
A meta-analysis evaluated the effects of fruit and vegetable consumption (FVC) interventions on weight loss in individuals with BMI >25 across 16 studies (17 comparisons, 3,719 participants). The overall summary effect showed significant weight loss (-2.81 kg; p < .001). Increased weight loss was significantly moderated by low socio-economic status (-4.99 kg; p < .001), higher baseline BMI (slope = -0.29; p = .047), longer interventions (slope = 0.012; p < .001), and recruitment setting (health care/programs: -3.7 kg, p < .001; work/academic settings: -5.2 kg, p < .001).
Arnotti K, Bamber M West J Nurs Res, 2020. PMID 31256714
2020 / Meta-analysis
A meta-analysis evaluated the links between obesity, bone mineral density, and osteoporosis in adults. Obesity was linked to higher bone mineral density in the lumbar spine (weighted mean difference 0.07 g/cm2; 95% CI: 0.045 to 0.095) and femoral neck (weighted mean difference 0.087 g/cm2; 95% CI: 0.063 to 0.112). General obesity was also linked to lower odds of femoral neck osteoporosis (OR 0.169; 95% CI: 0.132 to 0.216).
Qiao D, Li Y, Liu X, et al. Public Health, 2020. PMID 31837611
2020 / Systematic review and dose-response meta-analysis of RCTs
A systematic review and meta-analysis of eight randomized controlled trials evaluated the effects of psyllium in 395 diabetic participants. Psyllium consumption led to significant reductions in triglycerides (WMD: -19.18 mg/dl, 95% CI [-31.76, -6.60]), low-density lipoprotein (WMD: -8.96 mg/dl, 95% CI [-13.39, -4.52]), fasting blood sugar (WMD: -31.71 ml/dl, 95% CI [-50.04, -13.38]), and hemoglobin A1c (WMD: -0.91%, 95% CI [-1.31, -0.51]). There were no significant changes in high-density lipoprotein, body mass index, cholesterol, or weight.
Xiao Z, Chen H, Zhang Y, et al. Phytother Res, 2020. PMID 31919936
2020 / Systematic review of randomised controlled trials
A systematic review evaluated five acute randomised controlled trials with a total of 122 participants to determine the effects of mycoprotein on glycaemic control and energy intake. The results did not show a clear effect of acute mycoprotein on blood glucose levels, but indicated a decrease in insulin levels. Additionally, acute mycoprotein intake decreased energy intake at an ad libitum meal and post-24 h in healthy lean, overweight, and obese humans. The authors noted that evidence comes from a very limited number of heterogeneous studies.
Cherta-Murillo A, Lett AM, Frampton J, et al. Br J Nutr, 2020. PMID 32100651
2020 / Systematic review and meta-analysis of randomized controlled trials
Researchers conducted a systematic review and meta-analysis of 12 randomized clinical trials involving 849 subjects to evaluate the effects of berberine and barberry on anthropometric measures in adults. Berberine and barberry intake led to no significant changes in BMI (WMD: -0.16 kg/m2; 95% CI: -0.43 to 0.11, P = 0.247) or body weight (WMD: -0.11 kg; 95% CI: -0.13 to 0.91, P = 0.830). Berberine also showed no significant effect on waist circumference (WMD: -0.58 cm; 95% CI: -1.89 to 0.72, P = 0.379), but produced a significant reduction in waist-hip ratio (WMD: -0.03; 95% CI: -0.04 to -0.01, P < 0.0001).
Amini MR, Sheikhhossein F, Naghshi S, et al. Complement Ther Med, 2020. PMID 32147051
2020 / Systematic review of human and animal studies
A systematic review evaluated the impact of apple vinegar on metabolic parameters, body weight, safety, and side effects across 13 human and 12 animal studies. Researchers noted that while beneficial health effects may exist and the risk of side effects appears inconsiderable when ingested in recommended quantities and ways, current evidence remains insufficient. The authors concluded that more large-scale, long-term clinical studies with a low risk of bias are needed before definitive conclusions can be drawn.
Launholt TL, Kristiansen CB, Hjorth P Eur J Nutr, 2020. PMID 32170375
2020 / Cohort study and meta-analysis of prospective cohort studies
In an NHANES cohort of 24,856 participants (mean follow-up 6.4 years, 3,433 deaths), higher potato consumption was initially associated with higher risks of total (42%), CVD (65%), cerebrovascular (26%), and cancer (52%) mortality (p < 0.001), but these associations disappeared after adjustment for confounding factors. In a pooled meta-analysis of prospective studies (98,569 participants), potato intake showed no significant association with total (RR = 1.25, 95% CI 0.98-1.60), CVD (RR = 0.99, 95% CI 0.90-1.08), or stroke mortality (RR = 0.94, 95% CI 0.85-1.03). However, individuals with higher potato intake displayed less favorable cardiometabolic profiles, including higher waist circumference (97.2 vs. 99.5 cm) and worse blood pressure, triglycerides, HDL-C, and TG/HDL-C ratio (all p < 0.001).
Shows an association, not proof of cause and effect.
Mazidi M, Katsiki N, Mikhailidis DP, et al. Arch Med Sci, 2020. PMID 32190135
2020 / Systematic review of randomized controlled trials
Researchers conducted a systematic review of literature published between January 1990 and May 2019 to evaluate the effects of thylakoid or chloroplast intake on satiety and weight loss. Eight clinical trials met inclusion criteria. All included studies supported the hypothesis that thylakoids reduce hunger by increasing postprandial cholecystokinin and leptin and decreasing serum ghrelin. However, the effects of thylakoid consumption on anthropometric characteristics were controversial, and authors noted more studies are needed on long-term supplementation.
Amirinejad A, Heshmati J, Shidfar F J Diabetes Metab Disord, 2020. PMID 32550209
2020 / Meta-analysis and systematic review of observational studies
A systematic review and meta-analysis of 14 observational studies evaluated the link between BMI or waist circumference and hearing loss using random-effects models. In cross-sectional studies, prevalent hearing loss was associated with obesity (OR 1.40, 95% CI 1.14 to 1.72) and each 5 kg/m2 increase in BMI (OR 1.14, 95% CI 1.04 to 1.24), but not significantly with underweight, overweight, or higher WC. In longitudinal studies, hearing loss risk was significantly higher for overweight (RR 1.15, 95% CI 1.04 to 1.27), obesity (RR 1.38, 95% CI 1.07 to 1.79), each 5 kg/m2 increase in BMI (RR 1.15, 95% CI 1.01 to 1.30), and higher WC (RR 1.11, 95% CI 1.01 to 1.22).
Shows an association, not proof of cause and effect.
Yang JR, Hidayat K, Chen CL, et al. Environ Health Prev Med, 2020. PMID 32590951
2020 / Systematic review and meta-analysis of RCTs
A meta-analysis of 20 randomized controlled trials with 3,153 participants assessed the effects of vitamin D supplementation on general and central obesity indices. Compared with placebo, vitamin D did not significantly decrease BMI (WMD = -0.09 kg/m2, 95% CI -0.19 to 0.01, p = 0.08), WC (WMD = -0.71 cm, 95% CI -1.58 to 0.16, p = 0.112), or WHR (WMD = 0.00, 95% CI -0.01 to 0.01, p = 0.749), though serum 25(OH)D significantly increased (WMD = 13.20 ng/mL, 95% CI 9.83-16.58, p < 0.001). Significant reductions in BMI and WC were reported in subgroup analyses of females, studies in Asia, and interventions lasting ≥6 months (all p < 0.026).
Duan L, Han L, Liu Q, et al. Ann Nutr Metab, 2020. PMID 32645694
2020 / Systematic review and meta-analysis
A systematic review and meta-analysis evaluated risk factors, comorbidities, pharmacotherapy, and reversal of premature graying of hair (PGH). Smoking, vitamin deficiencies (B12, folic acid, and B7), and mineral deficiencies (low serum calcium and serum ferritin) were found to be associated with PGH. Other associated factors included obesity, high blood pressure, lack of exercise, and CAD. Low-grade recommendation (2A) was given to calcium pantothenate, PABA, and their combination, and treating accompanying pathologies led to disease reversal in many cases.
Shows an association, not proof of cause and effect.
Mahendiratta S, Sarma P, Kaur H, et al. Dermatol Ther, 2020. PMID 32654282
2020 / Systematic review and meta-analysis of administrative cohort studies
A systematic review and meta-analysis of 18 administrative database cohort studies evaluated 1,539,904 individuals (269,818 undergoing bariatric surgery and 1,270,086 controls) with at least 18 months of follow-up. Bariatric surgery was associated with reduced all-cause mortality (POR 0.62, 95% CI 0.55 to 0.69, p < 0.001) and cardiovascular mortality (POR 0.50, 95% CI 0.35 to 0.71, p < 0.001). It was also linked to reduced incidence of T2DM (POR 0.39), hypertension (POR 0.36), dyslipidaemia (POR 0.33), and ischemic heart disease (POR 0.46). Key limitations include inability to account for unmeasured variables due to non-randomised designs, heterogeneity in control groups, and lack of data on potential adverse surgical outcomes.
Shows an association, not proof of cause and effect.
Wiggins T, Guidozzi N, Welbourn R, et al. PLoS Med, 2020. PMID 32722673